Global Biodefense - posted on April 23, 2012
The National Emerging Infectious Diseases Laboratory (NEIDL), a high-security biolab constructed at Boston University, has been stalled by regulatory reviews and community opposition for nearly a decade. This month the lab finally started work at the Biosafety Level 2 (BSL-2) and hopes to expand into its full intended capacity of conducting BSL-3 and BSL-4 research.
NEIDL was a product of National Institutes of Health (NIH) federal grant funding awarded in 2003 to expand the biothreat research capabilities of the nation. During design and construction phases of the biolab, both NIH and Boston University performed Environmental Impact Studies which concluded that the risk to the community arising from the potential release of an infectious agent from the NEIDL was negligible.
Congratulations to United for Justice with Peace on your tenth year conference! I wish I could be with you in person today. However, I want to thank Duncan for making it possible for me to communicate with you through the written word. I also want to thank UJP as an organization and your members for the energy and commitment that you have put into our struggle for peace and justice at home.